Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Update on bevacizumab and other angiogenesis inhibitors for brain cancer.

Update on bevacizumab and other angiogenesis inhibitors for brain cancer. Expert Opin Emerg Drugs. 2013 Jun; 18(2):137-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.